ZNF385A Antikörper (C-Term)

Produktnummer ABIN927338

Produktdetails anti-ZNF385A Antikörper

Target: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte, Rind (Kuh), Zebrafisch (Danio rerio)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ZNF385A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Kreuzreaktivität: Maus, Ratte (Rattus), Zebrafisch (Brachydanio rerio), Rind (Kuh)

Aufreinigung: Purified

Immunogen: ZNF385 antibody was raised in rabbit using the C terminal of ZNF385 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

ZNF385 Blocking Peptide, catalog no. 33R-5098, is also available for use as a blocking control in assays to test for specificity of this ZNF385 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu ZNF385A

Target: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Andere Bezeichnung: ZNF385 (ZNF385A Produkte)

Synonyme: HZF antikoerper, RZF antikoerper, ZFP385 antikoerper, ZNF385 antikoerper, Hzf antikoerper, Zfp385 antikoerper, Znf385a antikoerper, si:dkey-228g21.6 antikoerper, wu:fj44b04 antikoerper, zinc finger protein 385A antikoerper, ZNF385A antikoerper, Zfp385a antikoerper, znf385a antikoerper

Hintergrund: Results suggest that RZF is a shuttling regulatory protein expressed in photoreceptors of the human retina that may be involved in mRNA or protein regulation of photoreceptor-specific genes and therefore have role in retinal disease mechanisms. Synonyms: Polyclonal ZNF385 antibody, Anti-ZNF385 antibody, zinc finger protein 385 antibody.

Pathways: Positive Regulation of Response to DNA Damage Stimulus, Negative Regulation of intrinsic apoptotic Signaling, Positive Regulation of fat Cell Differentiation